7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

IGM Biosciences, Inc
(NASDAQ:IGMS) 

IGMS stock logo

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Its lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 1 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymp...

Founded: 1993
Full Time Employees: 103
CEO: Fred M. Schwarzer  
Sector: Healthcare
Industry: Biotechnology
Pharmaceuticals
Share this website to your friends
IGM Biosciences Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 017.0234.0551.0768.0985.11102.14119.16
IGM Biosciences Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 019.5839.1758.7578.3497.92117.51137.09
IGM Biosciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.04-3.46-2.87-2.28-1.7-1.11-0.520.06
IGM Biosciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.34-3.72-3.1-2.48-1.86-1.24-0.620
IGM Biosciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.673.345.016.688.3510.0211.69
IGM Biosciences P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0389.82779.641,169.461,559.281,949.12,338.922,728.74
IGM Biosciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.86-4.17-3.47-2.78-2.08-1.39-0.690
IGM Biosciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.98-0.380.220.821.422.022.623.22
No extra charts and metrics for this ticker.